Harrow · 1 day ago
Associate Director, Medical Affairs
US
Full-time
Hybrid
Lead/Staff, Director/Executive
2+ years expHarrow is a leading North American ophthalmic-focused pharmaceutical company that values innovation and patient access to affordable medicines. The Associate Director of Medical Affairs will provide strategic and scientific expertise to support the company’s portfolio while developing medical plans, engaging with key opinion leaders, and ensuring alignment of medical strategies with clinical and commercial objectives.
BiotechnologyHealth CareMedical
Responsibilities
Work with medical leadership to develop and execute medical strategies to support Harrow’s product portfolio/disease areas of interest, maintaining alignment with corporate objectives
Manage Competitive Intelligence reports, tracking clinical studies, publications, and editorials of products in relevant fields of interest for Harrow, providing regular updates and assessments to key internal stakeholders
Provide medical and scientific input into brand planning, lifecycle management, and clinical development activities
Serve as a scientific expert across cross-functional teams, ensuring consistent and accurate communication of data and messaging
Develop high quality analysis of Investigator Initiated Study grant requests to ensure alignment with strategies, acceptable risk/benefit ratios, impact on current and future scientific landscape, and fair market budget assessments
Partner with Medical Commications and relevant internal and external colleagues to oversee dissemination of scientific data through publications, congress presentations, advisory boards, and symposia
Serve as reviewer in Medical/Regulatory/Legal panel for all assigned materials to ensure scientific accuracy, alignment with strategic messaging, and that materials are fair and balanced
Build and maintain strong relationships with KOLs, investigators, medical societies, centers of excellence, and other external experts in partnership with Field Medical
Represent the company at scientific congresses, advisory boards, and medical education events in partnership with Field Medical
Provide scientific and medical expertise to external stakeholders, ensuring timely and accurate information exchange in partnership with Field Medical
Manage Harrow Science’s online and social media presence
Maintain compliance with all legal, regulatory, and ethical standards
Qualification
Required
Terminal Degree MD/DO/OD/PhD/PharmD required
Extensive ophthalmic experience required
A minimum of 2 years of pharmaceutical industry experience in an internal strategic Medical Affairs role required
The ability to fluently read, write, understand, and communicate in English required
Preferred
Experience working with broad product portfolios is highly preferred
Successful record of designing and executing clinical trials preferred
Experience in scientific presentations and medical writing preferred
Broad knowledge of product development, regulatory requirements, payer landscape, and life cycle management preferred
Proven ability and experience to develop and foster peer-to-peer, credible relationships with Medical Experts/decision makers
Working knowledge of the Healthcare System and of the research procedures as well as the ICH guidelines, GCP, and other ethical guidelines
Strong analytical skills, ability to interpret scientific/clinical literature
Proficient with MS Office applications
Company
Harrow
Harrow (NASDAQ: HROW) is a growing leader in the ophthalmic healthcare market.
201-500 employees
H1B Sponsorship
Harrow has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2024 (1)
Funding
Current Stage
Public CompanyTotal Funding
$533.75MKey Investors
Oaktree Capital ManagementSWK Funding
2025-09-08Post Ipo Debt· $250M
2023-07-19Post Ipo Equity· $60M
2023-03-28Post Ipo Debt· $100M
Leadership Team
Mark L. Baum
Founder, CEO, and Chairman of the Board of Directors
Dennis Saadeh
Chief Scientific Officer
Recent News
2025-02-12
2025-02-12
Company data provided by crunchbase